Estimating The Number of COVID Vaccine Deaths in America

Download as pdf or txt
Download as pdf or txt
You are on page 1of 23

Estimating the number of COVID

vaccine deaths in America


By Jessica Rose, Mathew Crawford

Abstract: Analysis of the Vaccine Adverse Event Reporting System (VAERS) database can be
used to estimate the number of excess deaths caused by the COVID vaccines. A simple
analysis shows that it is likely that over 150,000 Americans have been killed by the current
COVID vaccines as of Aug 28, 2021.

The Vaccine Adverse Event Reporting System (VAERS) database is the only pharmacovigilance
database used by FDA and CDC that is accessible to the public. It is the only database to which
the public can voluntarily report injuries or deaths following vaccinations. Medical professionals
and pharmaceutical manufacturers are mandated to report serious injuries or deaths to VAERS
following vaccinations when they are made aware of them. It is a “passive” system with
uncertain reporting rates. VAERS is called the “early warning system” because it is intended to
reveal early signals of problems, which can then be evaluated carefully by using an “active”
surveillance system.

The VAERS database can be used to estimate the number of deaths caused by the COVID
vaccines using the following method:
1. Determine the significant adverse event under-reporting multiplier by using a known
significant adverse event rate
2. Determine the number of US deaths reported into VAERS
3. Determine the propensity to report significant adverse events this year
4. Estimate the number of excess deaths using these numbers
5. Validate the result using independent methods

Determining the VAERS under-reporting multiplier


One method to discover the VAERS underreporting analysis can be done using a specific
serious adverse event that should always be reported, data from the CDC, and a study
published in JAMA.

Anaphylaxis after COVID-19 vaccination is rare and occurs in approximately 2 to 5 people per
million vaccinated in the United States based on events reported to VAERS according to the
CDC report on Selected Adverse Events Reported after COVID-19 Vaccination.

Anaphylaxis is a well known side effect and doctors are required to report it. It occurs right after
the shot. You can’t miss it. It should always be reported.

Page 1
A study at Mass General Brigham (MGM) that assessed anaphylaxis in a clinical setting after
the administration of COVID-19 vaccines published in JAMA on March 8, 2021, found “severe
reactions consistent with anaphylaxis occurred at a rate of 2.47 per 10,000” people fully
vaccinated. This rate is based on reactions occurring within 2 hours of vaccination, the mean
time was 17 minutes after vaccination. This study used “active” surveillance and tried not to
miss any cases.

When asked about this, both the CDC and FDA sidestepped answering the question. Here’s
the proof at the CDC (see page 1 which incorporates the CDC response to the original letter on
pages 2 and 3).

As noted in the letter, this implies that VAERS is underreporting anaphylaxis by 50X to 123X.
The CDC chose not to respond to the letter.

Is the anaphylaxis under reporting rate a good proxy for reporting fatalities? Since anaphylaxis
is such an obvious association, one could argue that the rate would be a lower bound. Others
would argue that deaths are more important and would be more reported than anaphylaxis.

We don’t know, but it doesn’t matter because this is just an approximation to get to a ballpark
figure. In general, most of us think It is therefore entirely reasonable to assert that deaths are
reported even less frequently than anaphylaxis since deaths are not as proxmate to the injection
event.

The MGH study used practically identical criteria as CDC used in its study to define a case of
anaphylaxis.

We ran the numbers ourselves and confirmed this.Therefore, a conservative estimate (giving
the government the greatest benefit of the doubt) would use 50X as the underreporting rate.

However, after the MGH study was published, one doctor pointed out that doctors were more
careful to avoid anaphylaxis; there was more careful screening of people likely to have
anaphylaxis, and they were advised to see their allergist and take more precautions prior to
vaccination. This sort of thing would overstate the numbers above.

So we ran the numbers BEFORE the JAMA study appeared and got a more conservative
estimate.

Here’s the data from Google (which uses World In Data):

Page 2
Page 3
We’ve vaccinated 97.5M people from the start thru March 2021 and there were 583 reports in
VAERS who had an anaphylaxis reaction on their first dose. This suggests that the
underreporting rate is 41X.

Other estimates such as How Underreported Are Post-Vaccination Serious Injuries and Deaths
in VAERS? suggests a 30X factor based on VAERS. However, this used a serious adverse
event rate from the Pfizer Phase 3 study which we believe under-reported these events for three
reasons: 1) the patients were much healthier than average with a 10X lower rate of cardiac

Page 4
arrest than the general public (for example), 2) it was hard to report adverse events if you were
in the trial (the evidence of this was unfortunately deleted when Facebook removed the vaccine
side effect groups), and 3) there was known malfeasance in the reporting of adverse events in
the 12-15 year old trial where the paralysis of 12-year-old Maddie de Garay was never included
in the trial results and the FDA and CDC refused to investigate and the mainstream media
would not report on it.

The point of this paper is not to find the exact number of deaths, but merely to find the most
credible estimate for deaths. We think that anaphylaxis is an excellent proxy for a serious
adverse event that, like a death, should always be reported so we think 41X is the most
accurate number.

Our hypothesis is that this number will be applicable to deaths as well. In order to confirm our
hypothesis, we must derive the death count in different ways and see if we come up with the
same answer.

When used for less serious events, such as a headache, it’s likely that 41X is going to be low
since such events are less likely to be reported. So our hypothesis is that 41X is a safe,
conservative factor useful for both serious and less serious adverse events.

Determining the number of US deaths


As of August 27th, 2021, a search of the VAERS database shows that there are 7,149 domestic
deaths in the VAERS database (US/Territories/Unknown).

Estimate the propensity to report for 2021


Healthcare providers have been required by law to report serious adverse events in VAERS with
passage of the National Childhood Vaccine Injury Act (NCVIA) in 1986.

Therefore, nothing has changed this year vs. previous years:


1. no new legal requirements,
2. no noticeable promotion or incentives to report into VAERS.

Even when there are strong promotions to report adverse events as there was with H1N1 in
2009 where there were serious campaigns to raise the visibility of reporting, this didn’t impact
the background fatality event reporting: it didn’t go up at all in 2009 and 2010 as can be seen
from the graph below.

In short, it is extremely difficult to materially change the propensity to report serious adverse
events into the VAERS system; it is remarkably consistent from year to year. This makes sense:
old habits die hard… behaviors are hard to change. And there was nothing “new” this year to
incentivize a massive change in behavior.

Page 5
Look at the weekly data below. The massive increase in reporting pretty much happened almost
instantaneously as soon as the vaccines started rolling out. And it was proportional to the
rollout. That is not how behavioral change works… behavioral change would happen very slowly
over time; especially if you are trying to get doctors to change their long term behaviors. The
reporting basically followed the rollout of the vaccine. Doctors were more likely to report to
VAERS this year because there were simply more events to report. We have verified that by
talking directly to the doctors as the reason they are reporting more for these vaccines.

To double check our hypothesis that the propensity to report is unchanged this year, we ran
VAERS queries using symptoms unrelated to those impacted by the vaccines. We ruled out any
known comorbidities like diabetes and obesity since these would likely be elevated since there
are more adverse events.

We found that the reporting rates for these unrelated events (listed in the table below) are no
different this year than in previous years and for some of these events, the reporting rate is

Page 6
dramatically lower. Note that the number in the 2015-2019 column is the total for the 5 years,
not an average annual amount. The Rate Increase is an X factor (i.e., A/B*5)

Symptom 2021 2015-2019 Rate increase

Metal poisoning 2 47 0.22

Otitis media 48 255 0.94

Hepatitis 331 1457 1.13

Wart 1 7 0.71

Cancer 31 132 1.17

Breech delivery 0 3 0

A third way to see that 2021 isn’t simply over-reporting normal background adverse events is to
look at the “adverse event (AE) footprint” of the vaccine. You do that by listing adverse events
on the X-axis and AE counts on the Y-axis. If there is over-reporting this year, the overall outline
of the boxes will be exactly the same as previous years, and they will just be higher due to the
higher propensity to report the same types of events. As you can see, that is not the case here.
This vaccine is definitely causing a completely different “shape” of severe adverse events. Here
we show 2018, 2019, 2020, and 2021.

For a more detailed set of vaccine fingerprints (COVID vs. other vaccines), see these charts
from Jessica Rose.

Page 7
A fourth way to confirm there wasn’t over-reporting is through informal physician surveys. In our
informal physician surveys we saw a bias to under-report serious adverse events in order to
make the vaccines look as safe as possible to the American public since most physicians
believe they are hurting society if they do anything to create vaccine hesitancy. Secondly, we’d
estimate that at least 95% of physicians have completely bought into the “safe and effective”
narrative and thus any event that they observe they deem as simply anecdotal and don’t bother
to report it since it couldn’t have been caused by such a safe vaccine that appeared to do so
well in the Phase 3 trials.

Determining the number of excess deaths caused by


the COVID vaccines
There are three ways to estimate the number of excess deaths caused by the vaccine. Using
these three methods we can estimate the low and high likely bounds for the number of excess
deaths caused by the vaccine:
1. Subtract the average number of background deaths in previous years
2. Use 86% based on the analysis in the Mclachlan study
3. Use 40% based on the estimate of Dr. Peter Schirmacher one of the world’s top
pathologists

Here is the result we get from the three methods:

Method

Subtract average background deaths (7149-1000)*41 = 252,109

Maclachlan case analysis .86 * 41* 7149= 252,073

Pathologist estimate .60 * 41* 7149= 175,865

In the first method, we used 500 background deaths as normal for a year since the propensity to
report is the same this year as in previous years as shown earlier. However, we should assume
that the age cohort is older this year than previous years. For example, here are the vaccination
rates shown in a CDC report for influenza:

Page 8
So a conservative estimate is to take the <500 deaths per year and increase it by 50% to more
than account for a shift to higher ages so subtract 750 background deaths.

In the second method, McLachlan examined 250 VAERS reports in detail and concluded that up
to 86% of the deaths were consistent with the vaccine being causal for the death. We use the
higher number, because using a lower number makes no sense since it leads to a background
death rate that would be excessive compared to previous years (.14*7149 = 1,000 which is
already higher than the 500/yr background death rate).

The third method uses estimates made by Dr. Peter Schirmacher, one of the world’s top
pathologists, for the % of deaths examined by autopsy within 2 weeks of the vaccine that were
clearly caused by the vaccine. The range was from 30% to 40% and we used the high end of
the range since we believed that in making a potentially career-ending revelation such as this
that Dr. Schirmacher was being extremely conservative and only estimating what he was 100%
certain of proving. 40% is likely very conservative since Norway was under no such reputational
pressure and in the the first 13 bodies they assessed, 100% of the deaths were found to be
caused by the vaccine (see Norwegian Medicines Agency links 13 deaths to vaccine side
effects). Therefore using a 60% number seems relatively conservative (less than the 65%
average of 30 and 100).

Page 9
Therefore we have a range of death estimates from 148,000 to 216,000 deaths which averages
to 182,000 deaths.

Validation using other methods


In order to validate that our estimates are reasonable (or simply that the evidence was more
likely consistent with the hypothesis that the vaccine does more harm than good), we looked at
four different quantitative methods from very small to very large and summarized their estimates
in the table:

Method Estimate of US excess vaccine deaths

Excess CFR analysis done in Europe 72,000 - 180,000


determines 200-500 D/M doses

Excess death analysis done in 23 nations 147,960


(comprising 25% of world population) which
includes 2 Europe nations in the CFR
analysis which determined a 411 D/M doses.

Together, the two analyses cover 35% of the


global population

Small island study done by Marc Girardot 171,000

150,000
By mid-January, Norway had vaccinated
around 40,000 people. They had 23 reported
deaths, so 1 in 1700 (maybe more because
it's hard to know when such statements are
formulated relative to a program that was
vaccinating several thousand per day). That
scales to 575/M, and assuming a 2:1 ratio for
1st:2nd dose puts the U.S. in the ballpark of
150k deaths.

There are additional qualitative methods that show a large number of deaths. The point of these
method is to show that the FDA assumption that “the vaccines are safe and all of the reports in
VAERS are background events” is not even close to being true.

Example 5: The pericarditis data below shows that the number of events for these vaccines are
anything but safe: they generate myocarditis/pericarditis at 860 times the rate of the typical flu
vaccine in a year.

Page 10
A friend of ours got pericarditis right after getting the influenza vaccine when she was 30 years
old. It took her two years to recover. The heart muscle never really regenerates like other
organs unfortunately.

Example 6: A total of 23 deaths have been reported in connection with the corona vaccination
to the Norwegian Medicines Agency. Of those, 13 deaths were linked to the vaccine’s side
effects. The other 10 haven’t been evaluated yet. Thus, 100% of the reported deaths have been
deemed to be caused by the vaccine. If the vaccine is perfectly safe and has killed no one, then
this is statistically impossible. Someone is lying. The fact that there are no autopsies being done
in the US in public view suggests that it is more likely that the CDC is lying than the Norwegian
Medicines Agency.

Example #7: An analysis of excess deaths in Israel, especially among young people, that was
done by Dr. Steven Ohana, clearly shows a huge rise in excess deaths that have no explanation
other than the rollout of a mass vaccination program.

Example #8: A published analysis of VAERS data by Dr. Jessica Rose and a more recent
analysis of VAERS data done by Christine Cotton show massive numbers of cardiovascular and
neurological adverse events occurring within temporal proximity to the injection date.

Example #9: Causality of these adverse events is confirmed using Dose 1 and Dose 2 studies
done by Dr. Jessica Rose.

Page 11
Example #10: If the vaccine is perfectly safe, the number of deaths would be equally likely after
the first dose vs. the second dose since both are effectively “non-events.” Because there are
15% fewer people who get the second dose than the first dose, we should expect the blue bars
to be uniformly 15% lower than the red bars. This is not the case here. If the vaccine kills 50%
of the 1% most vulnerable people each time it is administered, this can explain the dramatic
drop off in events.

Another explanation is that the vulnerable population experienced severe adverse events
following Dose 1 and thus chose not to get a second Dose despite the societal pressure
(vaccine mandates, peer pressure, etc) to do so. It is likely a combination of both effects. Here is
an example of this from a comment posted to TrialSiteNews on A New Low For the FDA:

Page 12
Whatever the cause, evidence to support the arisal and reporting of multiple severe adverse
events that are dose-related is a very strong safety signal that requires investigation.

Example #11: The same commentary as before applies for cardiac arrest; a safe vaccine
should have blue bars on average 15% below the red bars.

Page 13
Example 12: Absolute numbers of VAERS reports plotted according to “time to death” is very
revealing. We don’t know what the exact distribution of timing looks like because this was never
measured. But we speculate that maximum accumulation of spike protein is achieved around 24
hours or so after injection and then it plateaus after that point as the mRNA disintegrates.
Therefore, we would expect to see a death peak more than 24 hours after injection, i.e., on Day
1 and not on Day 0 This is exactly what happens in practice:

If these were simply random background deaths, we would expect to see a peak on the first day
since that has the highest propensity to report, and it would drop from there; it would never peak
on Day 1. In the graph above, we plot 8 months of the COVID19 vaccine reports compared to all
death reports from all influenza vaccines for the past 10 years combined. So the blue line at 0 is
20 years of death reports, it is not an annual average. In short, the killing power of this vaccine
is at least 200X greater than the influenza vaccine and probably a lot more than that since
background deaths are included in both red and blue bars.

Furthermore, the shape of the two curves is completely different. The combined flu deaths are
relatively flat with a slight rise in the first few days. The COVID vaccine generally kills people
very quickly, and then gradually over time from there.

Example 13: A visual way to show that excess deaths are likely caused by the vaccine is to plot
vaccinations and deaths on the same axis using data from the COVID-19 data explorer. For

Page 14
Israel we get this chart which shows a correlation between vaccine booster doses given
(cumulative booster doses per 100 people) and average daily deaths per million: they track
almost in lock step. This is hard to explain any other way.

In summary, the qualitative and quantitative confirmation techniques we used were all
independent of each other and of our main method, yet all were consistent with the hypothesis
that the vaccines cause large numbers of serious adverse events and excess deaths and are
inconsistent with the null hypothesis that the vaccines have no effect on mortality and have a
safety profile comparable to that of other vaccines.

We were not able to find a single piece of evidence that supported the FDA and CDC position
that all the excess deaths were simply over-reporting of natural cause deaths.

Page 15
Serious adverse events elevated by the COVID
vaccines
We made a table comparing the rate of adverse events this year relative to the annual VAERS
incidence rate reported for all vaccines over the period from 2015-2019 for ages 20 to 60. We
limited the age range to show that these events are affecting young people and not just the
elderly. Also, the signal to noise ratio is much stronger in this younger age group since they are
less likely to suffer “background” adverse events. A value of 473 means the rate reported in
VAERS for the COVID19 vaccines in 2021 was 473 times higher than what is typical for all
vaccines combined in the typical average year.

Nearly all serious adverse events we looked at were strongly elevated compared to the
expected normal baseline event rate. This table is useful when assessing whether the vaccine
may have been involved in causing death in cases. The symptoms listed here are consistent
with the presumed mechanism of action for how these vaccines kill people (producing spike
protein throughout the body that cause inflammation, scarring, and blood clots).

Surprisingly, only a few of these symptoms appear in the labeling of the recently approved Pfizer
vaccine. Thus, this table is important and timely.

Symptom Incidence rate


elevation over normal
(X factor)

Pulmonary embolism 473

Stroke 326

Deep vein thrombosis 264.3

Thrombosis 250.5

Fibrin D dimer increased 220.8

Appendicitis 145.5

Tinnitus 97.3

Cardiac arrest 75

Death 58.1

Parkinson’s disease 55

Slow speech 54.3

Aphasia (inability to talk) 52.3

Page 16
Fatigue 50.9

Pericardial effusion 50.5

Headache 46.4

Chills 45.6

Pericarditis 44.9

Deafness 44.7

Myocarditis 43.2

Haemorrhage intracranial 42.5

Abortion Spontaneous 41.3

Cough 38.5

Bell’s Palsy 36.6

Paraesthesia 29.5

Blindness 29.1

Dyspnea (difficulty breathing) 28.4

Myalgia 28.4

Dysstasia (difficulty standing) 27.8

Seizure 27

Thrombocytopenia 25

Anaphylactic Reaction 21

Suicide 18.3

Speech disorder 17.2

Convulsion 16.3

Thrombotic thrombocytopenic 16.3


purpura (TTP)

Paralysis 16

Swelling 14.3

Diarrhoea 11.9

Page 17
Neuropathy 11.2

Multiple organ dysfunction 11.1


syndrome

Depression 8.9

Child deaths are consistent with symptoms elevated


by the COVID vaccines
Perhaps most troubling of all is child deaths.

The CDC VAERS review of the 12-17 year old data released on July 30, 2021 showed there
were 345 cases of myocarditis and 14 deaths. Unlike old people, kids don’t spontaneously die
every day at anywhere near the same rate.

Using the table above and investigating each death, all of these deaths where there was
sufficient detail in the death report showed that it involved one or more of the symptoms listed in
the elevated adverse event table.

14*41 = 574 deaths

There are fewer total child deaths for 17 and under (which is a much wider age range than
above) in the entire pandemic.

Page 18
Therefore, the cost benefit case for children isn’t there.

Lack of a stopping condition


In 1976, they halted the H1N1 vaccine after 500 GBS cases and 32 people died.

However, there is no stopping mortality condition for these vaccines. We are likely at 150,000
deaths and counting and nobody in the mainstream medical establishment, mainstream media,
or Congress is raising any concerns.

No member of the medical community is calling for any stopping condition nor autopsies. We
find this troubling.

Page 19
Negative efficacy
This paper shows that the vaccines we received may well shortly become completely useless
to protect us and, to make matters worse, might enhance the ability of future variants to
infect us due to vaccine enhanced infectivity/replication, rather than “classical” ADE.

In short, even if the vaccine were perfectly safe and killed no one, it’s rapidly becoming a net
negative based on efficacy alone.

We are starting to see evidence of this today. UK data destroys entire premise for vaccine push.
August 21. 2021. “Again, 402 deaths out of 47,008 cases or 0.855% CFR in fully vaccinated,
and; 253 deaths out of 151,054 cases or 0.17% CFR in unvaccinated. If you get Covid having
been fully vaccinated, according to this UK data, you are five (5) times more likely to die than
if you were not vaccinated!”

All-cause mortality is the single most important thing


to focus on and it’s not there
Today, most people focus on the relative risk reduction of the vaccines against infection,
hospitalization death from COVID. They pay less attention to the absolute risk reduction from
COVID. And they pay no attention at all to the absolute all-cause mortality benefit.

The funny thing is that we should be paying attention to these in the opposite order that we
listed them.

All-cause mortality is key. If there is no improvement in all-cause mortality, nothing else


matters.

In short, say our vaccine reduces the risk of dying from COVID by 2X. But it came at a cost,
e.g., increasing your risk of dying from a heart attack by 4X. And let’s say both events are
equally likely (which they aren’t). Then you’ve made a bad decision… you’re more likely to die if
you took the vaccine.

Here are the results from the Pfizer 6-month study:

Phase Vaccine deaths Placebo deaths

14
Pre-unblinding 15

Page 20
0
Post-unblinding 5

Discussion of these results is quite a bit more complex than we have space to go into here, but
these are the basic stats. For more information, see the 10-page discussion of the Pfizer 6
month trial at Why so many Americans are refusing to get vaccinated.

All the all cause mortality numbers are negative from the 6 month Pfizer study. This is not a
surprise: it is caused by the high rates of adverse events we’ve already discussed.

There is no evidence of statistically significant mortality improvement.

If there was the CDC, FDA, and NIH would certainly let us know. But just the opposite
happened: when the Pfizer 6 month study came out, the mainstream media and mainstream
medical scientists were silent on the lack of all-cause mortality evidence. It didn’t even make it
into the abstract. The fact that 4 times as many people were killed by cardiac arrest wasn’t even
mentioned.

When you combine (1) the negative efficacy of the vaccine with (2) the negative all-cause
mortality benefit, it’s impossible to justify vaccination. Either alone is sufficient to kill the benefit;
both of them together makes things even more difficult for recommending vaccination.

The bottom line is clear: If you got the vaccine you were simply more likely to die. The younger
you are, the greater the disparity.

Early treatment using repurposed drugs has always


been the safer and easier way to treat COVID
infections
Early treatment protocols such as those used by Fareed and Tyson have been shown to provide
more than a 99% relative risk reduction, work for all variants, and the drugs don’t maim or harm
the recipients. It is baffling that we are ignoring these treatments and waiting for more evidence
when we have a vaccine which appears to kill more people than it saves, soon will be
completely useless against future variants, and is likely going to make things worse for the
recipient by enhancing replication and/or infectivity.

There are also a variety of prophylaxis techniques that are simple, safe, and highly effective
including. The precautionary principle suggests that if there is evidence from a credible source
of the benefits of these treatments (which there are), that doctors should discuss these
treatments with patients in a shared decision-making process.

Page 21
Because early treatments using repurposed drugs don’t create a measurable risk of death, the
all-cause mortality for early treatments is always positive.

Many people assume that vaccination is the only path forward. It isn’t. Allowing people to be
infected and develop recovered immunity leads to immunity which is broader against variants
and lasts longer. See “Recovered immunity is broader and longer lasting” in this document.

It is instructive to compare Israel with India.

Israel is one of the most vaccinated countries on Earth with 80 percent of citizens above the age
of 12 fully inoculated. As of Aug 24, 2021, Israel reported 9,831 new diagnosed cases on
Tuesday, a hairbreadth away from the worst daily figure ever recorded in the
country—10,000—at the peak of the third wave.

At the same time, India recorded 354 deaths in a day, Israel was reporting 26 deaths and
record high cases. Here’s how they stack up:

Country Population (M) Vaccination rate Covid deaths per


million

India 1395 9.5% 0.25

Israel 8.7 80% 2.9

Obviously, India has 11.6X lower deaths per capita than Israel.

The conclusion is clear, vaccination is not the only solution nor the best solution.

Summary
Using the VAERS database and independent rates of anaphylaxis events from a Mass General
study, we computed a 41X under-reporting factor for serious adverse events in VAERS, leading
to an estimate of over 150,000 excess deaths caused by the vaccine.

The estimates were validated multiple independent ways.

There is no evidence that these vaccines save more lives than they cost. Pfizer’s own study
showed that adverse events consistent with the vaccine were greater than the lives saved by
the vaccine to yield a net negative benefit. Without an overall statistically significant all-cause
mortality benefit, and evidence of an optional medical intervention that has likely killed over

Page 22
150,000 Americans so far, vaccination mandates are not justifiable and should be opposed by
all members of the medical community.

Early treatments using a cocktail of repurposed drugs with proven safety profiles are a safer,
more effective alternative which always improves all-cause mortality in the event of infection and
there are also safe, simple, and effective protocols for prophylaxis.

Page 23

You might also like